TXG Stock Recent News

PLEASANTON, Calif. , July 10, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced it will report financial results for the second quarter ended June 30, 2025 after market close on Thursday, August 7, 2025.

Toronto, Ontario--(Newsfile Corp. - June 18, 2025) - Torex Gold Resources Inc. (the "Company" or "Torex") (TSX: TXG) announces the results of its 2025 annual and special meeting of shareholders (the "Meeting") held virtually today. ITEM 1. ELECTION OF DIRECTORS At the Meeting, all director nominees listed in the Company's management information circular (the "Circular") dated May 7, 2025, were elected as directors of the Company.

Toronto, Ontario--(Newsfile Corp. - June 17, 2025) - Jody Kuzenko, President & Chief Executive Officer, Torex Gold Resources Inc. ("Torex" or the "Company") (TSX: TXG), and her team, joined Dean McPherson, Head, Business Development, Global Mining, Toronto Stock Exchange (TSX), to close the market and celebrate the Company's 15th anniversary of being listed on TSX. Cannot view this video?

Report shines a spotlight on continued leadership in responsible mining (All amounts expressed in U.S. dollars unless otherwise stated) Toronto, Ontario--(Newsfile Corp. - June 12, 2025) - Torex Gold Resources Inc. (the "Company" or "Torex") (TSX: TXG) today released its 2024 Responsible Gold Mining Report (the "Report") titled Building from Strength, the Company's tenth annual disclosure of its safety, environmental, social and governance performance. The Report can be found on the Company's website at www.torexgold.com.

The average of price targets set by Wall Street analysts indicates a potential upside of 43.1% in 10x Genomics (TXG). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Toronto, Ontario--(Newsfile Corp. - May 26, 2025) - Torex Gold Resources Inc. (the "Company" or "Torex") (TSX: TXG) announces that an amendment to the Company's restricted share unit plan (the "RSU Plan") will be included in the matters to be presented to shareholders at the annual and special meeting of shareholders of Torex scheduled to be held on June 18, 2025 (the "Meeting"). The RSU Amendment is being made in response to comments from a proxy voting advisory and corporate governance services firm (the “Proxy Advisory Firm”).

Gene sequencing technology company 10x Genomics (TXG 2.52%) hasn't been having it easy in the past few days on the stock market. A bearish analyst move dampened sentiment on the company, and according to data compiled by S&P Global Market Intelligence its price was down by more than 9% week to date as of early Friday morning.

10x Genomics (TXG) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Results continue to indicate high-grade mineralization and the long-term potential of the deposit (All amounts expressed in U.S. dollars unless otherwise stated) Toronto, Ontario--(Newsfile Corp. - May 20, 2025) - Torex Gold Resources Inc. (the "Company" or "Torex") (TSX: TXG) is pleased to provide remaining results from the 2024 drilling program and initial results from the 2025 drilling program at ELG Underground. The results support the Company's target of further extending the mine life of ELG Underground by identifying new zones of higher-grade mineralization, expanding resources within known areas, and replacing mined reserves.

PLEASANTON, Calif. , May 14, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced that it has reached a settlement agreement with Bruker Corporation, successfully resolving all outstanding worldwide patent litigation and disputes between the two companies.